1. Introduction.. 2

MIME-Version: 1.0Content-Type: multipart/related; boundary="----=_NextPart_01C9119B.74EB4AB0"

This document is a Single File Web Page, also known as a Web Archive file. If you are seeing this message, your browser or editor doesn't support Web Archive files. Please download a browser that supports Web Archive, such as Microsoft Internet Explorer.

------=_NextPart_01C9119B.74EB4AB0Content-Location: file:///C:/E328C6E5/P1006.htmContent-Transfer-Encoding: quoted-printableContent-Type: text/html; charset="us-ascii"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"xmlns:o=3D"urn:schemas-microsoft-com:office:office"xmlns:w=3D"urn:schemas-microsoft-com:office:word"xmlns:st1=3D"urn:schemas-microsoft-com:office:smarttags"xmlns=3D"http://www.w3.org/TR/REC-html40">

<head><meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dus-ascii"><meta name=3DProgId content=3DWord.Document><meta name=3DGenerator content=3D"Microsoft Word 11"><meta name=3DOriginator content=3D"Microsoft Word 11"><link rel=3DFile-List href=3D"P1006_files/filelist.xml"><link rel=3DEdit-Time-Data href=3D"P1006_files/editdata.mso"><title>PLEASE REFER TO ANZFA’S GUIDE TO APPLICATIONS AND PROPOSALS FO=R AMORE DETAILED EXPLANATION OF THE PROCESS ON HOW TO UNDERTAKE</title><o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags" name=3D"place"/><o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags" name=3D"country-region"/><o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags" name=3D"State"/><o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags" name=3D"City"/><style></style></head>

<body lang=3DEN-AU link=3D"#000000" vlink=3Dpurple style=3D'tab-interval:1.=0cm'>

<div class=3DSection1>

<![if !vml]><img width=3D416 height=3D73src=3D"P1006_files/image002.jpg" v:shapes=3D"_x0000_i1025"><![endif]><o:p><=/o:p>

<o:p> </o:p>

15 September 2008<o:p></o:p>

[16-08]<o:p></o:p>

<o:p> </o:p>

PROPOSAL P1006&=nbsp;<o:p></o:p>

REC=ONSIDERATIONOF THE URGENT REMOVAL OF A COMMENCEMENT PROVISION FOR CERTAIN SPECIAL PURPO=SEINFANT FORMULA<o:p></o:p>

ASS=ESSMENT

REPORT <o:p></o:p>

<div style=3D'mso-element:para-border-div;border:none;border-bottom:solid w=indowtext 1.5pt;padding:0cm 0cm 1.0pt 0cm'>

<s=panlang=3DEN-GB style=3D'font-size:12.0pt;font-family:Tahoma'><o:p> </o:p=>

</div>

<o:p> </o:p>

<a name=3D"_Toc11735626"></a><a name=3D"_Toc29883108">=</a><aname=3D"_Toc41906795"></a><a name=3D"_Toc41907543"></a><a name=3D"_Toc12009=0537"></a><aname=3D"_Toc120358570"></a><a name=3D"_Toc120358612">Exe=cutiveSummary</a><spanstyle=3D'mso-bookmark:_Toc11735626'><spanstyle=3D'mso-bookmark:_Toc41906795'><spanstyle=3D'mso-bookmark:_Toc120090537'><spanstyle=3D'mso-bookmark:_Toc120358612'><o:p></o:p>

<a name=3D"_Toc120090538"></a><a name=3D"_Toc120358571="></a><aname=3D"_Toc120358613"><spanstyle=3D'mso-bookmark:_Toc120090538'><o:p> </o:p></a><=/p>

<spanstyle=3D'mso-bookmark:_Toc120358613'>

The purposeof this Assessment Report is to re-consider a variation to Standard 2.9.1– Infant Formula Products of the AustraliaNew Zealand Food Standards Code (the Code) made in June 2008 under thesection 95 urgency provisions of the FoodStandards Australia New Zealand Act 1991 (FSANZ Act), that removed acommencement provision relating to certain special purpose infant formula<astyle=3D'mso-footnote-id:ftn1' href=3D"#_ftn1" name=3D"_ftnref1" title=3D""=><spanclass=3DMsoFootnoteReference><![if !supportFootnotes]><spanclass=3DMsoFootnoteReference><span lang=3DEN-GB style=3D'font-size:11.0pt;m=so-bidi-font-size:12.0pt;font-family:Arial;mso-fareast-font-family:"Times New Roman";mso-ansi=-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>[1]=<![endif]></a>.<spanstyle=3D'mso-spacerun:yes'> <o:p></o:p>

<o:p> </o:p>

Theamendment to the Code was made after a Declaration of Urgency and preparati=on ofa draft variation which was gazetted on 30 June 2008.<spanstyle=3D'mso-spacerun:yes'> <o:p></o:p>


In May2008 it was brought to Food Standards Australia New Zealand’s(FSANZ’s) attention that the commencement of the operation of subclau=se27(2) of Standard 2.9.1 on 20 June 2007, and the conditions that it applied,may have adversely constrained manufacturers in formulating infant formulaproducts for particular metabolic, immunological, renal, hepatic andmalabsorptive conditions. Manufacturers who are formulating these types of special purpose inf=antformula may technically have been in breach of the Code and open to enforce=mentaction.<o:p></o:p>


Thissituation created uncertainty for:<o:p></o:p>

<spanstyle=3D'mso-spacerun:yes'> <o:p></o:p>

<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>the infant formula indust=ry incontinuing to formulate and supply these special purpose infant formulaproducts within <st1:country-region w:st=3D"on">Australia</st1:country-regi=

on>and <st1:place w:st=3D"on"><st1:country-region w:st=3D"on">New Zealand</st1=:country-region></st1:place>;


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>infants with medical cond=itionswho may be solely reliant on these infant formula products to meet theirparticular nutritional requirements; and


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>State/Territory and New Z=ealandGovernment agencies responsible for enforcing the Code.<o:p></o:p></=p>

<spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'><o:p> </o:p><=/p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:12.0pt;font=-family:Arial;mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'> 

Giventhe concern that the commencement provision may have unintentionallyjeopardised the availability and supply of certain special purpose infantformula to infants with particular medical conditions, FSANZ, for public he=althand safety reasons, decided pursuant to section 95 of the FSANZ Act, to dec=lareProposal P1006 as urgent and to seek an emergency amendment to the Code. <o=:p></o:p>


Following Initial Consideration of Pro=posalP1006 the commencement provision in clause 27 of Standard 2.9.1 was removed= soas to:<o:p></o:p>

<o:p> </o:p>

<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>protect the public health= andsafety of infants with specific medical conditions who rely on special purp=oseinfant formula products to meet their particular nutritional requirements; =and<o:p></o:p>

<o=:p> </o:p>

<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>ensure infant formula man=ufacturersare not unduly hindered in the formulation and supply of special purpose in=fantformula.<o:p></o:p>


Inaccordance with section 101 of the FSANZ Act, the Authority must now either= re‑affirmits decision to approve the urgent variation; or prepare a proposal within =12months of the standard taking effect. <o:p></o:p>

<o:p> </o:p>

Therefore,the specific objective of this assessment is to either: re-affirm the decis=ionto amend clause 27 of Standard 2.9.1; or to consider the need to prepare a =new(separate) proposal for a further variation or replacement variation to cla=use27 of Standard 2.9.1.<o:p></o:p>


T<a name=3D"_Toc120090541"></a><aname=3D"_Toc120358573"></a><a name=3D"_Toc120358615">he following two regulatory options ar=

e nowavailable for Proposal P1006:<o:p></o:p></a>

<spanstyle=3D'mso-bookmark:_Toc120358573'><spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial;background:yellow;mso-high=light:yellow'><o:p> </o:p>

<spanstyle=3D'mso-bookmark:_Toc120358615'><spanstyle=3D'mso-bookmark:_Toc120090541'>Option 1 </s=pan>re-affirmthe amendment made to clause 27 of Standard 2.9.1 which removed thecommencement provision (subclause 27(3) andconsequentially removed subclause 27(2)): or<sp=anstyle=3D'mso-bookmark:_Toc120358615'><spanstyle=3D'mso-bookmark:_Toc120090541'><o:p></o:p>

<spanstyle=3D'mso-bookmark:_Toc120358615'><spanstyle=3D'mso-bookmark:_Toc120090541'><o:p> </o:p>

<spanstyle=3D'mso-bookmark:_Toc120358615'><spanstyle=3D'mso-bookmark:_Toc120090541'>Option 2 </s=pan>preparea new (separate) proposal which may result in the amendments made to clause= 27of Standard 2.9.1 being varied or replaced.<spanstyle=3D'mso-spacerun:yes'> <o:p></o:p></=span>

<sp=anstyle=3D'mso-bookmark:_Toc120358615'><spanstyle=3D'mso-bookmark:_Toc120090541'><o:p> </o:p>

<spanstyle=3D'mso-bookmark:_Toc120358615'>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

Preferred option:<o:p></o:p><=

/span>

<o:p> </o:p>

FSANZ’spreferred approach is to <spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>re-affirm the amendment m=ade toclause 27 of Standard 2.9.1 – Infants Formu=laProducts that removed the commencement provision (subclause 27(3) andconsequentially removed subclause 27(2)).<o:p></o:p>

</div>


Reasonsfor Preferred Approach<o:p></o:p></b=>

<h3><o:p> </o:p></h3>

FSANZ is recommending that the vari=ation toclause 27 of Standard 2.9.1 (see Attachment 1) be reaffirmed as it provides= netbenefits to all affected parties. </=span><o:p></o:p>


The amendment:<o:p></o:p>


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>retains the <istyle=3D'mso-bidi-font-style:normal'>status quo approach to permitting =infantformulas to be specifically formulated to satisfy particular metabolic,immunological, renal, hepatic and malabsorptive conditions;<o:p></o:p></spa=n>


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=;

<![endif]>protects the public healt=h andsafety of infants with particular nutritional requirements by ensuring that= theavailability and supply of special purpose infant formulas in <st1:country-=regionw:st=3D"on">Australia</st1:country-region> and <st1:country-region w:st=3D"=on"><st1:place w:st=3D"on">New Zealand</st1:place></st1:country-region> is not unduly hin=dered;and <o:p></o:p>


<span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:12.0pt;font=-family:Arial;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:"Times= New Roman";mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'=><brclear=3Dall style=3D'page-break-before:always'>

<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>provides certainty forconsumers, industry and enforcement agencies on the regulatory status ofspecial purpose infant formula.<o:p></o:p>


<spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>The preferred option woul=d retainthe variation to clause 27 of Standard 2.9.1 which was gazetted and came in=toeffect on 30 June 2008.<o:p></o:p>


<a name=3D"_Toc120090542"></a><a name=3D"_Toc120358574="></a><aname=3D"_Toc120358616"><spanstyle=3D'mso-bookmark:_Toc120090542'>Consultation</a><o:p></o:p>


Under the urgencyprovisions of section 95 of the FSANZ Act, FSANZ conducted six business day=s (sevenbusiness days in <st1:State w:st=3D"on">Western Australia</st1:State> and <=st1:country-regionw:st=3D"on"><st1:place w:st=3D"on">New Zealand</st1:place></st1:country-reg=ion>) of

public consultation during the Initial Consideration of Proposal P1006.<spanstyle=3D'mso-spacerun:yes'> During the consultation period of =6-17June 2008, FSANZ received 10 submissions.&=nbsp;A summary of submissions is at Attachment 2.<spanstyle=3D'mso-spacerun:yes'> All submitters supported making theproposed urgent amendment to the Code. <o:p></o:p>

<o:p> </o:p>

A number of submitterscommented on FSANZ’s proposed future plan for considering the regulat=ionof special purpose infant formula over the longer term.<spanstyle=3D'mso-spacerun:yes'> Whilst noting that development ofrelevant Ministerial Council policy guidelines is underway, most submitterssupported progression of this future work as a priority once Ministerial po=licyguidance is received by FSANZ.<o:p></o:p>

<o:p> </o:p></sp=an>

Concern was also expr=essedthat action to amend clause 27 of Standard 2.9.1 was not initiated until af=terthe commencement clause came into effect and that other similar clauses mayexist in the Code. <sp=anlang=3DEN-GB style=3D'font-size:10.0pt'>In response, FSANZ has undertaken =anaudit of the Code and no other clauses require attention in a manner which =gaverise to this urgent Proposal.<o:p></o:p>


<a name=3D"_Toc11735627"><spanlang=3DEN-GB style=3D'font-size:10.0pt;mso-bidi-font-family:Arial'>Invitati=on forSubmissions<o:p></o:p></a>

<o:p> </o:p></sp=an>

FSANZ invites public comment on this Report and =the

variations to the Code based on regulationimpact principles for the purpose of re-considering the urgent amendment to= theCode as approval by the FSANZ Board.<o:p></o:p>

<o:p> </o:p>

Written submissions are invited from interestedindividuals and organisations to assist FSANZ in further considering thisProposal. Submissions should,= wherepossible, address the objectives of FSANZ as set out in section 18 of the F=SANZAct. Information providing de=tailsof potential costs and benefits of the proposed change to the Code fromstakeholders is highly desirable. Claims made in submissions should be supported wherever possible byreferencing or including relevant studies, research findings, trials, surve=ysetc. Technical information sh=ouldbe in sufficient detail to allow independent scientific assessment.<o:p></o=:p>

<o:p> </o:p>

<spanstyle=3D'font-size:10.0pt;color:black;mso-ansi-language:EN-AU'>The processe=s ofFSANZ are open to public scrutiny, and any submissions received will ordina=rilybe placed on the public register of FSANZ and made available forinspection. If you wish anyinformation contained in a submission to remain confidential to FSANZ, youshould clearly identify the sensitive information, separate it from yoursubmission and provide justification for treating it as confidential commer=cialmaterial. Section 114 of =theFSANZ Act requires FSANZ to treat in‑confidence, trade secretsrelating to food and any other information relating to food, the commercialvalue of which would be, or could reasonably be expected to be, destroyed ordiminished by disclosure.<o:p></o:p>

<spanstyle=3D'font-size:10.0pt;color:black;mso-ansi-language:EN-AU'><o:p> <=/o:p>

<spanstyle=3D'font-size:10.0pt;color:black;mso-ansi-language:EN-AU'>Submissions =mustbe made in writing and should clearly be marked with the word‘Submission’ and quote the correct project number and name.<spanstyle=3D'mso-spacerun:yes'> While FSANZ accepts submissions in= hardcopy to our offices, it is more convenient and quicker to receive submissio=ns

electronically through the FSANZ website using the Standards Development=tab and then through Documents for Public Comment.<spanstyle=3D'mso-spacerun:yes'> Alternatively, you may email yoursubmission directly to the Standards Management Officer at <s=panstyle=3D'mso-bookmark:_Toc11735627'><ahref=3D"mailto:[email protected]"><spanstyle=3D'font-size:10.0pt;mso-bidi-font-family:Arial;mso-ansi-language:EN-A=U'>[email protected]<spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'font-size:10.0pt;color:black;mso-ansi-language:EN-AU'>.<spanstyle=3D'mso-spacerun:yes'> There is no need to send a hard co=py ofyour submission if you have submitted it by email or the FSANZ website.<spanstyle=3D'mso-spacerun:yes'> FSANZ endeavours to formally ackno=wledgereceipt of submissions within 3 business days.<o:p></o:p>

<spanstyle=3D'font-size:10.0pt;mso-bidi-font-family:Arial;color:black;mso-ansi-l=anguage:EN-AU'><o:p> </o:p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-paginati=on:none;tab-stops:396.0pt;mso-layout-grid-align:none;text-autospace:none;border:non=e;mso-border-alt:solid windowtext 1.5pt;padding:0cm;mso-padding-alt:1.0pt 4.0=pt 1.0pt 4.0pt'><spanstyle=3D'mso-bookmark:_Toc11735627'>DEADLINE FOR PUBLIC SUBMISSIONS</sp=an><spanstyle=3D'mso-bookmark:_Toc11735627'>:<spanstyle=3D'mso-bookmark:_Toc11735627'> =6pm(<st1:place w:st=3D"on"><st1:City w:st=3D"on">Canberra</st1:City></st1:plac=e> time)17 October 2008<o:p></o:p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-paginati=on:none;tab-stops:396.0pt;mso-layout-grid-align:none;text-autospace:none;border:non=e;mso-border-alt:solid windowtext 1.5pt;padding:0cm;mso-padding-alt:1.0pt 4.0=pt 1.0pt 4.0pt'><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p> </o:p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-paginati=

on:none;mso-layout-grid-align:none;text-autospace:none;border:none;mso-border-alt:s=olid windowtext 1.5pt;padding:0cm;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>SUBMISSIONS RECEIVED AFTER THIS DEADLINE WILL NOT= BECONSIDERED<o:p></o:p>

</div>

<spanstyle=3D'mso-bookmark:_Toc11735627'><o:p> </o:p>

<span style=3D'font-size:10.0pt;font-family:Arial;mso-fareast-font-family:"=Times New Roman";mso-bidi-font-family:"Times New Roman";mso-ansi-language:EN-AU;mso-fareast-=language:EN-US;mso-bidi-language:AR-SA'> 

<spanstyle=3D'font-size:10.0pt;mso-ansi-language:EN-AU'>Submissions received aft=erthis date will only be considered if agreement for an extension has been gi=venprior to this closing date. <=o:p></o:p>

<spanstyle=3D'font-size:10.0pt;mso-ansi-language:EN-AU'><o:p> </o:p>=

<spanstyle=3D'font-size:10.0pt;mso-ansi-language:EN-AU'>Agreement to an extensio=n oftime will only be given if extraordinary circumstances warrant an extension= tothe submission period. Any ag=reedextension will be notified on the FSANZ website and will apply to allsubmitters.<o:p></o:p>


<spanstyle=3D'font-size:10.0pt;mso-ansi-language:EN-AU'>Questions relating to ma=kingsubmissions or the application process can be directed to the StandardsManagement Officer at <ahref=3D"mailto:[email protected]">[email protected]</=span></a><spanstyle=3D'font-size:10.0pt;mso-ansi-language:EN-AU'>. <o:p></o:p></sp=an>


<spanstyle=3D'font-size:10.0pt;mso-ansi-language:EN-AU'>If you are unable to sub=mityour submission electronically, hard copy submissions may be sent to one of= thefollowing addresses:<o:p></o:p>

<o:p> </o:p></sp=an>

<spanlang=3DEN-GB style=3D'font-size:10.0pt;mso-bidi-font-family:Arial'>Food Sta=ndardsAustralia New Zealand &nbs=p; FoodStandards Australia New Zealand PO Box 7186 &n=bsp; &nbsp=; &n=bsp; &nbsp=; <=/span>POBox 10559 Canberra BC ACT 2610 &nbsp=; &n=bsp; &nbsp=; TheTerrace WELLINGTON 6036 AUSTRALIA &nbs=p; &=nbsp; &nbs=p; &=nbsp; &nbs=p; NEWZEALAND Tel (02) 6271 2222 <spanstyle=3D'mso-tab-count:2'> &=nbsp; &nbs=p; &=nbsp; &nbs=p; Tel(04) 473 9942 <![if !supportLineBreakNewLine]> <![endif]><spanlang=3DEN-GB style=3D'font-size:10.0pt;mso-bidi-font-family:Arial'><o:p></o=:p>

</div>

<span lang=3DEN-GB style=3D'font-s=ize:14.0pt;mso-bidi-font-size:10.0pt;font-family:Arial;mso-fareast-font-family:"Times =New Roman";mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'=><brclear=3Dall style=3D'page-break-before:always;mso-break-type:section-break'>

<div class=3DSection2>

<spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>CONTENTS<o:p></o:p></span=>

<o:p> </o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208605"><spanstyle=3D'mso-bookmark:_Toc11735627'>1.<spanstyle=3D'font-family:"Times New Roman";mso-ansi-language:EN-AU;mso-fareast-=language:EN-AU;mso-no-proof:yes;text-decoration:none;text-underline:none'><spanstyle=3D'mso-tab-count:1'> <spanlang=3DEN-GB style=3D'text-transform:uppercase;mso-no-proof:yes'>Introducti=on<spanstyle=3D'mso-bookmark:_Toc11735627'>.. </spa=n><spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;text-transform:uppercase;mso-no-proof:yes;text-decoration:none;text-underline:none'>2<spanlang=3DEN-GB><spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p><=/o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208606"><spanstyle=3D'mso-bookmark:_Toc11735627'>2.<spanstyle=3D'font-family:"Times New Roman";mso-ansi-language:EN-AU;mso-fareast-=language:EN-AU;mso-no-proof:yes;text-decoration:none;text-underline:none'><spanstyle=3D'mso-tab-count:1'> <spanlang=3DEN-GB style=3D'text-transform:uppercase;mso-no-proof:yes'>The Issue /Problem.. <spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;text-transform:uppercase;mso-no-proof:yes;text-decoration:none;text-underline:none'>2<spanlang=3DEN-GB><spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p><=/o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208607"><spanstyle=3D'mso-bookmark:_Toc11735627'>2.1<spanstyle=3D'font-family:"Times New Roman";mso-ansi-language:EN-AU;mso-fareast-=language:EN-AU;font-style:normal;mso-no-proof:yes;text-decoration:none;text-underlin=e:none'> =

<spanlang=3DEN-GB style=3D'mso-bidi-font-weight:bold;mso-no-proof:yes'>Requireme=nts ofthe FSANZ Act<spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;mso-no-proof:yes;text-de=coration:none;text-underline:none'> </=span><spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;mso-no-proof:yes;text-de=coration:none;text-underline:none'>3<spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p></o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208608"><spanstyle=3D'mso-bookmark:_Toc11735627'>3.<spanstyle=3D'mso-bookmark:_Toc11735627'> &nbsp=; <spanstyle=3D'mso-bookmark:_Toc11735627'>Objectives<s=panstyle=3D'mso-bookmark:_Toc11735627'>.. </spa=n><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;text-transform:uppercase;mso-no-proof:yes;text-decoration:none;text-underline:none'>4<spanlang=3DEN-GB><spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p><=/o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208609"><spanstyle=3D'mso-bookmark:_Toc11735627'>4.<spanstyle=3D'font-family:"Times New Roman";mso-ansi-language:EN-AU;mso-fareast-=language:EN-AU;mso-no-proof:yes;text-decoration:none;text-underline:none'><spanstyle=3D'mso-tab-count:1'> <spanlang=3DEN-GB style=3D'text-transform:uppercase;mso-no-proof:yes'>Relevant I=ssues<spanstyle=3D'mso-bookmark:_Toc11735627'>.. </spa=n><spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;text-transform:uppercase;mso-no-proof:yes;text-decoration:none;text-underline:none'>5<spanlang=3DEN-GB><spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p><=/o:p>

<a href=3D"#_Toc208208610"><spanstyle=3D'mso-bookmark:_Toc11735627'>4.1<spanstyle=3D'mso-bookmark:_Toc11735627'><spanstyle=3D'mso-tab-count:1'> </spa=n><spanlang=3DEN-GB style=3D'mso-no-proof:yes'>Historical background to Clause 27<=/span><spanstyle=3D'mso-bookmark:_Toc11735627'>=<spanstyle=3D'mso-tab-count:1 dotted'>. <spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;mso-no-proof:yes;text-de=coration:none;text-underline:none'>5<spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p></o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208611"><spanstyle=3D'mso-bookmark:_Toc11735627'>4.2<spanstyle=3D'mso-bookmark:_Toc11735627'><spanstyle=3D'mso-tab-count:1'> </spa=n><spanlang=3DEN-GB style=3D'mso-no-proof:yes'>Special purpose infant formula</spa=n><spanstyle=3D'mso-bookmark:_Toc11735627'>=<spanstyle=3D'mso-tab-count:1 dotted'>. <spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;mso-no-proof:yes;text-de=coration:none;text-underline:none'>5<spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p></o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208612"><spanstyle=3D'mso-bookmark:_Toc11735627'>4.3<spanstyle=3D'mso-bookmark:_Toc11735627'><spanstyle=3D'mso-tab-count:1'> </spa=n><spanlang=3DEN-GB style=3D'mso-no-proof:yes'>Division 3 – Infant Formula P=roductsfor Special Dietary Use<spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;mso-no-proof:yes;text-de=coration:none;text-underline:none'>. <=/span><spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;mso-no-proof:yes;text-de=coration:none;text-underline:none'>6<spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p></o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208613"><spanstyle=3D'mso-bookmark:_Toc11735627'>4.4<spanstyle=3D'mso-bookmark:_Toc11735627'><spanstyle=3D'mso-tab-count:1'> </spa=n><spanlang=3DEN-GB style=3D'mso-no-proof:yes'>Future FSANZ work<spanstyle=3D'mso-bookmark:_Toc11735627'>=<spanstyle=3D'mso-tab-count:1 dotted'>. <spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;mso-no-proof:yes;text-de=coration:none;text-underline:none'>7<spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p></o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208614"><spanstyle=3D'mso-bookmark:_Toc11735627'>5.<spanstyle=3D'font-family:"Times New Roman";mso-ansi-language:EN-AU;mso-fareast-=language:EN-AU;mso-no-proof:yes;text-decoration:none;text-underline:none'><spanstyle=3D'mso-tab-count:1'> <spanlang=3DEN-GB style=3D'text-transform:uppercase;mso-no-proof:yes'>Options</s=pan><spanstyle=3D'mso-bookmark:_Toc11735627'>.. </spa=n><spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;text-transform:uppercase;mso-no-proof:yes;text-decoration:none;text-underline:none'>7<spanlang=3DEN-GB><spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p><=/o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208615"><spanstyle=3D'mso-bookmark:_Toc11735627'>6.<spanstyle=3D'font-family:"Times New Roman";mso-ansi-language:EN-AU;mso-fareast-=language:EN-AU;mso-no-proof:yes;text-decoration:none;text-underline:none'><spanstyle=3D'mso-tab-count:1'> <spanlang=3DEN-GB style=3D'text-transform:uppercase;mso-no-proof:yes'>Impact Ana=lysis<spanstyle=3D'mso-bookmark:_Toc11735627'>.. </spa=n><spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;text-transform:uppercase;mso-no-proof:yes;text-decoration:none;text-underline:none'>7<spanlang=3DEN-GB><spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p><=/o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208616"><spanstyle=3D'mso-bookmark:_Toc11735627'>6.1<spanstyle=3D'mso-bookmark:_Toc11735627'><spanstyle=3D'mso-tab-count:1'> </spa=n><spanlang=3DEN-GB style=3D'mso-no-proof:yes'>Affected Parties<spanstyle=3D'mso-bookmark:_Toc11735627'>=<spanstyle=3D'mso-tab-count:1 dotted'>. <spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;mso-no-proof:yes;text-de=coration:none;text-underline:none'>8<spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p></o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208617"><spanstyle=3D'mso-bookmark:_Toc11735627'>6.2<spanstyle=3D'mso-bookmark:_Toc11735627'><spanstyle=3D'mso-tab-count:1'> </spa=n><spanlang=3DEN-GB style=3D'mso-no-proof:yes'>Benefit Cost Analysis=<spanstyle=3D'mso-bookmark:_Toc11735627'>=<spanstyle=3D'mso-tab-count:1 dotted'>. <spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;mso-no-proof:yes;text-de=coration:none;text-underline:none'>8<spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p></o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208618"><spanstyle=3D'mso-bookmark:_Toc11735627'>7.<spanstyle=3D'font-family:"Times New Roman";mso-ansi-language:EN-AU;mso-fareast-=language:EN-AU;mso-no-proof:yes;text-decoration:none;text-underline:none'><spanstyle=3D'mso-tab-count:1'> <spanlang=3DEN-GB style=3D'text-transform:uppercase;mso-no-proof:yes'>Consultati=on<spanstyle=3D'mso-bookmark:_Toc11735627'>.. </spa=n><spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;text-transform:uppercase;mso-no-proof:yes;text-decoration:none;text-underline:none'>9<spanlang=3DEN-GB><spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p><=/o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208619"><spanstyle=3D'mso-bookmark:_Toc11735627'>7.1<spanstyle=3D'mso-bookmark:_Toc11735627'><spanstyle=3D'mso-tab-count:1'> </spa=n><spanlang=3DEN-GB style=3D'mso-no-proof:yes'>World Trade Organization (WTO)</spa=n><spanstyle=3D'mso-bookmark:_Toc11735627'>=<spanstyle=3D'mso-tab-count:1 dotted'> <spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;mso-no-proof:yes;text-de=coration:none;text-underline:none'>9<spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p></o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208620"><spanstyle=3D'mso-bookmark:_Toc11735627'>8.<spanstyle=3D'font-family:"Times New Roman";mso-ansi-language:EN-AU;mso-fareast-=language:

EN-AU;mso-no-proof:yes;text-decoration:none;text-underline:none'><spanstyle=3D'mso-tab-count:1'> <spanlang=3DEN-GB style=3D'text-transform:uppercase;mso-no-proof:yes'>Conclusion= andPreferred Option<sp=anlang=3DEN-GB style=3D'display:none;mso-hide:screen;text-transform:uppercase;mso-no-proof:yes;text-decoration:none;text-underline:none'><spanstyle=3D'mso-tab-count:1 dotted'>.. <spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;text-transform:uppercase;mso-no-proof:yes;text-decoration:none;text-underline:none'>10<spanlang=3DEN-GB><spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p><=/o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><a href=3D"#_Toc208208621"><spanstyle=3D'mso-bookmark:_Toc11735627'>8.1<spanstyle=3D'mso-bookmark:_Toc11735627'><spanstyle=3D'mso-tab-count:1'> </spa=n><spanlang=3DEN-GB style=3D'mso-no-proof:yes'>Reasons for Decision<=spanstyle=3D'mso-bookmark:_Toc11735627'>=<spanstyle=3D'mso-tab-count:1 dotted'>. <spanstyle=3D'mso-bookmark:_Toc11735627'>10<spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p></o:p>

<a href=3D"#_Toc208208622"><spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial;text-transform:uppercase;mso-no-proof:yes'>Attachment 1 - </a><ahref=3D"#_Toc208208623">Variationto the Australia New Zealand FoodStandards Code as gazetted on 30 June 2008.<spanstyle=3D'mso-bookmark:_Toc11735627'> =<spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;text-transform:uppercase;mso-no-proof:yes;text-decoration:none;text-underline:none'>11<spanlang=3DEN-GB><spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p><=/o:p>

<a href=3D"#_Toc208208624"><spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial;text-transform:uppercase;mso-no-proof:yes'>Attachment 2 - </a><ahref=3D"#_Toc208208625">P1006 - Summary ofSubmissions at Initial Consideration<spanstyle=3D'mso-tab-count:1 dotted'>.. <spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'display:none;mso-hide:screen;text-transform:uppercase;mso-no-proof:yes;text-decoration:none;text-underline:none'>12<spanlang=3DEN-GB><spanstyle=3D'mso-bookmark:_Toc11735627'></a><spanstyle=3D'mso-bookmark:_Toc11735627'><o:p><=/o:p>

<spanstyle=3D'mso-bookmark:_Toc11735627'><spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'><o:p> </o:p><=/span>

<span lang=3DEN-GB style=3D'font-size:14.0pt;font-family:Arial;mso-fareast-=font-family:"Arial Unicode MS";mso-bidi-font-family:"Arial Unicode MS";mso-ansi-languag=e:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'> 

<h2><a name=3D"_Toc208208605"></a=><aname=3D"_Toc29883110"></a><a name=3D"_Toc41906797"></a><a name=3D"_Toc41907=544"></a><a

name=3D"_Toc120358575"><spanstyle=3D'mso-bookmark:_Toc41906797'><spanstyle=3D'mso-bookmark:_Toc208208605'>1. Introduction</s=pan></a><spanlang=3DEN-GB><o:p></o:p></h2>

<a name=3D"_Toc120358576"><o:p>&nbs=p;</o:p></a>



Thepurpose of this Assessment Report is to re-consider a variation made in June2008 to Standard 2.9.1 – Infant Formula Products of the <istyle=3D'mso-bidi-font-style:normal'>Australia New Zealand Food Standards C=ode(the Code) that removed a commencement provision relating to certain specialpurpose infant formula<a style=3D'mso-footnote-id:ftn2' href=3D"#_ftn2"name=3D"_ftnref2" title=3D""><spanstyle=3D'mso-special-character:footnote'><![if !supportFootnotes]><spanclass=3DMsoFootnoteReference><span lang=3DEN-GB style=3D'font-size:11.0pt;m=so-bidi-font-size:12.0pt;font-family:Arial;mso-fareast-font-family:"Times New Roman";mso-ansi=-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'>[2]=<![endif]></a>. This amendment was made follo=wingInitial Consideration of Proposal P1006 using urgency provisions under sect=ion95 of the Food Standards Australia =NewZealand Act 1991 (the FSANZ Act), and was gazetted on 30 June 2008.<spanstyle=3D'mso-spacerun:yes'> <o:p></o:p>


Underthe urgency provisions (section 95) of the FSANZ Act, the key basis forexercising these powers is to resolve an immediate problem with the operati=onof the Code; in this case clause 27 of Standard 2.9.1.<spanstyle=3D'mso-spacerun:yes'> Once approved, FSANZ must within 12months of the date of effect of the gazetted amendment, undertake an assess=mentof the resulting variation to the Code, call for public comment and reconsi=derits decision.<o:p></o:p>


ThisReport therefore re-visits the decision made following Initial Consideratio=n ofProposal P1006 and allows further opportunity for public consultation on theresulting urgent amendment as gazetted on 30 June 2008. <o:p></o:p><=

/p>


<h2><a name=3D"_Toc208208606"></a><a name=3D"_Toc11735631"></a><aname=3D"_Toc29883115"></a><a name=3D"_Toc41906802"></a><a name=3D"_Toc41907=549"></a><aname=3D"_Toc120358579"><spanstyle=3D'mso-bookmark:_Toc41906802'><spanstyle=3D'mso-bookmark:_Toc11735631'><spanlang=3DEN-GB>2. &nbs=p; </a><spanstyle=3D'mso-bookmark:_Toc208208606'>The Issue / Problem=<spanlang=3DEN-GB><o:p></o:p></h2>


Standard2.9.1 provides the compositional and labelling requirements for infant form=ulaproducts, including those intended for infants with special nutritionalrequirements. Prior to Propos=alP1006 and the resultant variation to the Code, Subdivision 2, Division 3 ofStandard 2.9.1 included the following clause:<o:p></o:p>


27&nbsp=; Composition<o:p></=o:p>

<o:p> </o:p>

<spanlang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>(1) Subject tosubclause (2), infant formula products may be specifically formulated tosatisfy particular metabolic, immunological, renal, hepatic or malabsorptiveconditions.<o:p></o:p>


<spanlang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>(2) The permis=sion

in subclause (1) only applies where the infant formula products comply with–<o:p></o:p>


(a)&nbs=p; thisDivision; and<o:p></o:p>

(b)&nbs=p; allthe other requirements of this Standard that are not inconsistent with thisDivision.<o:p></o:p>


<spanlang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>(3) Other thanfor the operation of clause 28, subclause (2) takes effect 5 years after thecommencement of this Standard.<o:p></o:p>

<o:p>&nb=sp;</o:p>

AsStandard 2.9.1 was gazetted on 20 June 2002, subclause 27(3) commencedoperation on 20 June 2007, being five years after the commencement of Stand=ard2.9.1. The commencement effec=t ofsubclause 27(3) related to subclause 27(2) which applied conditions to thepermission allowing infant formula products to be specifically formulated f=or <spanlang=3DEN-GB>particular metabolic, immunological, renal, hepatic or malabso=rptiveconditions (as provided in subclause 27(1)).<o:p></o:p>



In May2008, the commencement of the operation of subclause 27(2) of Standard 2.9.=1 on

20 June 2007, and the conditions that it applied might adversely constrainmanufacturers in formulating infant formula products for particular metabol=ic,immunological, renal, hepatic and malabsorptive conditions, was brought toFSANZ’s attention. Manufacturers who are formulating these types of special purpose inf=antformula may technically have been in breach of the Code and open to enforce=mentaction.<o:p></o:p>


Thissituation created uncertainty for:<o:p></o:p>


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>the infant formula indust=ry incontinuing to formulate and supply these special purpose infant formulaproducts within <st1:country-region w:st=3D"on">Australia</st1:country-regi=on>and <st1:place w:st=3D"on"><st1:country-region w:st=3D"on">New Zealand</st1=:country-region></st1:place>;


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>infants with medical cond=itionswho may be solely reliant on these infant formula products to meet theirparticular nutritional requirements; and


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>State/Territory and New Z=ealandGovernment agencies responsible for enforcing the Code.<o:p></o:p></=p>


Also,there was a significant risk to the public health and safety of a veryvulnerable population group i.e. infants with medical conditions, should in=fantformula manufacturers be hindered in the supply of these special purpose in=fantformula products.<o:p></o:p>


Giventhe concern that the commencement provision may have unintentionallyjeopardised the availability and supply of certain special purpose infantformula to infants with particular medical conditions, FSANZ, for public he=althand safety reasons, decided, pursuant to section 95 of the FSANZ Act, todeclare Proposal P1006 as urgent and to seek an emergency amendment to theCode. <o:p></o:p>


Fo=llowingInitial Consideration of Proposal P1006, an amendment to the Code was gazet=tedon 30 June 2008 which removed the commencement provision in clause 27 of St=andard2.9.1. Attachment 1 provides =thevariation to clause 27 of Standard 2.9.1 as gazetted following InitialConsideration.<o:p></o:p>


<h3><a name=3D"_Toc208208607">2.1 Requirements of =theFSANZ Act</a></h3>


The FSANZ Act, D<a name=3D"_Toc1725=23560">ivision 4– Urgent applications and proposals</a>, requires that if FSANZ appro=vesa draft standard or a draft variation of a standard <a name=3D"_Toc17252356=5">underthe urgency provisions, FSANZ must also assess the resulting standard orvariation</a> within 12 months of the date of effect of the gazettedvariation. 


Division 4 Subsection 99(2) require=s thatin assessing the standard or variation, the Authority must have regard to t=hefollowing matters:<o:p></o:p>


<spanlang=3DEN-GB>(a) </=span>whet<istyle=3D'mso-bidi-font-style:normal'>her costs that have arisen, or will ar=ise,from the standard or variation outweigh the direct and indirect benefits to= thecommunity, Government or industry that have arisen, or will arise, from thestandard or variation;<o:p></o:p>

<istyle=3D'mso-bidi-font-style:normal'>(b) whether other measures (available to theAuthority or not) would be more cost‑effective than the standard or v=ariation;<o:p></o:p>

<istyle=3D'mso-bidi-font-style:normal'>(c) all relevant <st1:country-region w:st=3D="on"><st1:place w:st=3D"on">New Zealand</st1:place></st1:country-region> standards;<o:p></=o:p>

<istyle=3D'mso-bidi-font-style:normal'>(d) any otherrelevant matters.

<spanstyle=3D'font-size:12.0pt;font-family:Arial'><o:p> </o:p></=p>

Also, in assessing the standard orvariation, FSANZ must call for public submissions.<a name=3D"_Toc172523569"=><spanstyle=3D'mso-spacerun:yes'> Division 4 Section 101 requires th=at </a>afterthe submission period, and within 12 months after the standard or variationtakes effect, FSANZ must:<o:p></o:p>


&nb=sp; <istyle=3D'mso-bidi-font-style:normal'>(a)&nb=sp; re‑affirmits decision to approve the standard or variation; or<o:p></o:p>=

<spanstyle=3D'mso-tab-count:1'> &=nbsp; (b)<spanstyle=3D'mso-tab-count:1'> prepare a proposalunder section 55 for the development of:<o:p></o:p>

 &=nbsp; (i)<spanstyle=3D'mso-tab-count:1'> the variati=on, orfurther variation, of the relevant standard; or<o:p></o:p>

<spanstyle=3D'mso-tab-count:1'> &=nbsp; (ii)<spanstyle=3D'mso-tab-count:1'> a replaceme=ntstandard.<o:p></o:p>


<h2><a name=3D"_Toc120358585"></a><a name=3D"_Toc208208608">3.<s=panstyle=3D'mso-tab-count:1'> </span=>Objectives</a><spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'><o:p></o:p></h2>


Inaccordance with the requirements of the FSANZ Act, the specific objective ofthis assessment is to re-consider the urgent variation made to clause 27 ofStandard 2.9.1 and to either: re-affirm the original decision made in June =2008which removed the previous commencement provision; or to consider the need =toprepare a new separate proposal to consider a further variation or replacem=entvariation to <o:p></o:p>

clause27.<o:p></o:p>


The original specific objectives of th=isProposal were to seek the removal of the commencement provision in clause 2=7 ofStandard 2.9.1 so as to:<o:p></o:p>


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>protect the public health= and

safety of infants with specific medical conditions who rely on special purp=ose infantformula products to meet their particular nutritional requirements; and<o:p=></o:p>

<o=:p> </o:p>

<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>ensure infant formulamanufacturers are not unduly hindered in the formulation and supply of spec=ialpurpose infant formula.<o:p></o:p>


In developing or varying a food standa=rd,FSANZ is required by its legislation to meet three primary objectives which= areset out in section 18 of the FSANZ Act.&nb=sp;These are:<o:p></o:p>


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>the protection of public =healthand safety; and


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>the provision of adequateinformation relating to food to enable consumers to make informed choices; =and


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=

; <![endif]>the prevention of mislead=ing ordeceptive conduct.


In developing and varying standards, F=SANZmust also have regard to:<o:p></o:p>


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>the need for standards to= bebased on risk analysis using the best available scientific evidence;=


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>the promotion of consiste=ncybetween domestic and international food standards;


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>the desirability of anefficient and internationally competitive food industry;


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>the promotion of fair tra=dingin food; and


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>any written policy guidel=inesformulated by the Ministerial Council.<o:p></o:p>


<span lang=3DEN-GB style=3D'font-size:14.0pt;font-family:Arial;mso-farea=st-font-family:"Arial Unicode MS";mso-bidi-font-family:"Arial Unicode MS";mso-ansi-languag=e:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;mso-bidi-font-styl=e:italic'> 

<h2><a name=3D"_Toc208208609">4. RelevantIssues</a> <o:p></o:p></h2>


<h3><a name=3D"_Toc208208610">4.1<=spanstyle=3D'mso-tab-count:1'> =Historicalbackground to Clause 27</a>=<o:p></o:p></h3>

<o:p> </=o:p>

During the re=view ofinfant formula (Proposal P93), FSANZ (then the Australia New Zealand FoodAuthority (ANZFA)) proposed to allow infant formula products to be specific=allyformulated to satisfy particular medical conditions provided that in allrespects such formula complied with the requirements of the proposed draftStandard 2.9.1.<o:p></o:p>


At Supplement=ary FinalAssessment (March 2002) of Proposal P93, the infant formula industry raisedconcerns that infant formula for specific clinical purposes should be allow=edto adhere with accepted international norms for those purposes.<spanstyle=3D'mso-spacerun:yes'> It was noted that <spanlang=3DEN-GB>special purpose infant formula did not comply with the standar=d baseformulation as proposed in draft Standard 2.9.1.<spanstyle=3D'mso-spacerun:yes'> <o:p></o:p>


Manufacturers also indicated that g=

iven thesmall volume of the market in <st1:country-region w:st=3D"on">Australia</st=1:country-region>and <st1:place w:st=3D"on"><st1:country-region w:st=3D"on">New Zealand</st1=:country-region></st1:place>and the global nature of manufacturing, they would be unable to modifyformulations to comply with the proposed draft =Standard,and may need to withdraw supply of these formulations to sick babies.<o:p><=/o:p>


At the time t=he thenANZFA noted that the supply of these infant formula products needed to beguaranteed for obvious health and safety reasons and concluded:<o:p></o:p><=/span>


Therefore, although it is =proposedthat special purpose products are expected to conform to the base standard =forhealthy infants except where necessary to meet theparticular needs of the infant with the special condition, ANZFA is proposi=ngto include a temporary exemption for the compositional requirements of thestandard to permit the supply of these products.<spanstyle=3D'mso-spacerun:yes'> The exemption isrecommended for a period of five years from the adoption of the standard.<s=panstyle=3D'mso-spacerun:yes'> This period will allow ANZFA to de=velopa special standard for ‘foods for special medical purposes’ thatcould include these highly specialised infant formula products. This willensure that the particular needs of these infants are protected.<spanstyle=3D'mso-spacerun:yes'> <o:p></o:p>


Howeverfor a variety of reasons, FSANZ was not able to complete work on a standard= forfoods for special medical purposes within the predetermined five year exemp=tionperiod. Work on a standard forfoods for special medical purposes (Proposal P242) commenced in 2001, but h=asbeen at Final Assessment since 2004.<o:p></o:p>


<h3><a name=3D"_Toc208208611">4.2 Special purpose

infant formula</a><o:p></o:p></h3>


Specialpurpose infant formulas are designed to be used under medical supervision tomeet the particular nutritional needs of infants with medical conditions.<s=panstyle=3D'mso-spacerun:yes'> These medical conditions can be qu=iterare and in some circumstances breastfeeding and standard milk-based infantformula may be unsuitable. <o=:p></o:p>


Manyspecial purpose infant formulas are available only through prescription and= aresubsided through the respective Australian and New Zealand Government subsi=dyschemes (e.g. PBS<a style=3D'mso-footnote-id:ftn3' href=3D"#_ftn3" name=3D"=_ftnref3"title=3D""><![if !supportFootnotes]><spanlang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:12.0pt;font-famil=y:Arial;mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=st-language:EN-US;mso-bidi-language:AR-SA'>[3]<![endif]></a=>, <spanlang=3DEN-GB>PHARMAC<a style=3D'mso-footnote-id:ftn4' href=3D"#_ftn4" name==3D"_ftnref4"title=3D""><![if !supportFootnotes]><spanlang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:12.0pt;font-famil=y:Arial;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:"Times New R=oman";mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'=>[4]<![endif]></a><spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>).<o:p></o:p>


Thereare only a small number of manufacturers who supply the domestic market withspecial purpose infant formulas. </s=pan><o:p></o:p>


Mostproducts are formulated and manufactured overseas for global supply, andimported into <st1:country-region w:st=3D"on">Australia</st1:country-region=> and <st1:placew:st=3D"on"><st1:country-region w:st=3D"on">New Zealand</st1:country-region=></st1:place>.<spanstyle=3D'mso-spacerun:yes'> It is therefore vital for health a=ndsafety reasons that the on-going availability and supply of these products =forinfants with particular nutritional needs can continue unhindered.<o:p></o:=p>


<h3><a name=3D"_Toc208208612">4.3 Division 3 &#821=1;Infant Formula Products for Special Dietary Use</a><o:p></o:p></h3>

<o:p> </o:p>

Division 3 of Standard 2.9.1 <spanlang=3DEN-GB>provides the compositional and labelling requirements for infa=ntformula products for special dietary use in three subdivisions:<o=:p></o:p>


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>Subdivision 1 – Inf=antformula products formulated for premature or low birthweight infants;<o:p><=/o:p>


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>Subdivision 2 – Inf=antformula products for metabolic, immunological, renal, hepatic and malabsorp=tiveconditions; and<o:p></o:p>


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>Subdivision 3 – Inf=antformula products for specific dietary use based upon protein substitutes.<o=:p></o:p>


The amendments made to clause 27 un=der ProposalP1006 urgency provisions are only intended to affect those products regulat=edby Subdivision 2 and do not impact on the infant formula products covered bythe other two subdivisions. Additionally, provisions relating to the composition and labelling oflactose free and low lactose infant formulas (clauses 29 and 30) are notaffected by the amendments and continue to operate.<o:p></o:p>


<h4>4.3.1 &nb=sp; Subdivision2 – Infant formula products for metabolic, immunological, renal, hepa=ticand malabsorptive conditions<o:p></o:p></h4>


<h5>4.3.1.1 =Composition<o:p></o:p></h5>


FSANZhas not been made aware of any evidence that the regulatory approach taken,including the permission to specifically formulate special purpose infantformulas, has not provided adequate protection of public health and safetyduring the relevant five-year exemption period since June 2002.<spanstyle=3D'mso-spacerun:yes'> Additionally, any<spanlang=3DEN-GB> risks associated with these types of infant formulas are gene=rallyminimised by their use under medical supervision.<o:p></o:p>


Inpreparing Proposal P1006, FSANZ considered that there was in fact a greaterrisk to public health and safety if these products were not allowed to cont=inueunder the regulatory arrangement put in place in June 2002. Therefore FSANZremoved the commencement provision in clause 27 to, in effect, continue the= status quo and to resolve theuncertainty created by the end of the five-year exemption period in June 20=07.<o:p></o:p>


FollowingInitial Consideration of Proposal P1006 the Code was amended to removesubclauses 27(2) and 27(3). However, it was expected that manufacturers would be able to formula=tespecial purpose infant formula within the requirements of Division 3, so theamendment was drafted to reflect this (see Attachment 1).<o:p></o:p>=


<h5>4.3.1.2 =Labelling<o:p></o:p></h5>


Infant formula products specificallyformulated for particular metabolic, immunological, renal, hepatic andmalabsorptive conditions have specific labelling requirements.<spanstyle=3D'mso-spacerun:yes'> Clause 28 of Standard 2.9.1 requir=esthese products to be labelled with:<o:p></o:p>



<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>advice that the product i=s notsuitable for general use and should be used under medical supervision;<o:p>=</o:p>


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>the condition, disease ordisorder for which the food has been formulated; and<o:p></o:p>


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>the nutritional modificat=ionsmade to the product.<o:p></o:p>


Thislabelling is considered important to ensure the safe and appropriate use ofthese special purpose infant formulas.&nbs=p;The amendments to clause 27 do not affect these labelling requiremen=ts. <o:p></o:p>

<h3><o:p> </o:p></h3>

<h3 style=3D'margin-left:42.75pt;text-indent:-42.75pt;mso-list:l10 level2 l=fo9;tab-stops:list 42.75pt'><a name=3D"_Toc208208613"><![if !supportLists]><spanlang=3DEN-GB style=3D'mso-fareast-font-family:Arial;mso-bidi-font-family:Ar=ial'><spanstyle=3D'mso-list:Ignore'>4.4&=nbsp; &nbs=p; <![endif]>Future FSANZ work<=/a><spanlang=3DEN-GB><o:p></o:p></h3>


FSANZproposes to undertake a review of the infant formula standard in relation tothe broader consideration of the regulation of special purpose infant formu=la:the scope and timing of this review is yet to be determined. <o:p></o:p></s=pan>


The <st1:placew:st=3D"on"><st1:country-region w:st=3D"on">Australia</st1:country-region><=/st1:place>and New Zealand Food Regulation Ministerial Council (Ministerial Council) iscurrently developing separate policy guidelines on the intent of Part 2.9

– Special Purpose Foods, and on infant formula products.<spanstyle=3D'mso-spacerun:yes'> It is anticipated that work on the=seguidelines will not be completed until late 2009.<o:p></o:p>


As FSANZ must have regard to any Minister=ialCouncil policy guidelines when developing or varying food standar=ds, itis therefore expected that a review of the infant formula standard andcompletion of work on Proposal P242 – Foods for Special Medical Purpo=seswill await completion of these policy guidelines.<spanstyle=3D'mso-spacerun:yes'> <o:p></o:p>


<h2><a name=3D"_Toc11735636"></a><a name=3D"_Toc29883121"></a><a name=3D"_T=oc41906808"></a><aname=3D"_Toc41907555"></a><a name=3D"_Toc120358586"></a><a name=3D"_Toc2082=08614"><spanstyle=3D'mso-bookmark:_Toc120358586'><spanstyle=3D'mso-bookmark:_Toc41906808'><spanstyle=3D'mso-bookmark:_Toc11735636'>5. Options<=/span></a><spanlang=3DEN-GB> <o:p></o:p></h2>


Inreconsidering the variation made to the Code under the urgency provisions, =thefollowing two regulatory options are available:<o:p></o:p>

<o:p> </o:p>

<spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>Option 1 re-affirm the resulting amendment made toclause 27 of Standard 2.9.1 which removed the commencement provision </span=><spanlang=3DEN-GB>(subclause 27(3) and consequentially removed subclause 27(2))<=/span><spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>; or.<o:p></o:p></=p>

<o:p> </o:p><=/p>

<spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>Option 2 prepare a new (separate) proposal which =mayresult in the amendments made to clause 27 of Standard 2.9.1 being varied orreplaced. <o:p></o:p><=/p>

<sp=anlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'><o:p> </o:p><=/p>

UnderOption 2 a new proposal would re-consider the operation of clause 27 ofStandard 2.9.1 including consideration of any unintended consequences orunresolved issues resulting from the urgent amendments made to clause 27.<s=panstyle=3D'mso-spacerun:yes'> During consideration of this= newproposal the amendments to clause 27 as gazetted on 30 June 2008 would rema=inin place. <o:p></o:p>


<h2><a name=3D"_Toc11735637"></a><a name=3D"_Toc29883122"></a><a name=3D"_T=oc41906809"></a><aname=3D"_Toc41907556"></a><a name=3D"_Toc120358587"></a><a name=3D"_Toc2082=08615"><spanstyle=3D'mso-bookmark:_Toc120358587'><spanstyle=3D'mso-bookmark:_Toc41906809'><spanstyle=3D'mso-bookmark:_Toc11735637'>6. Impact Analysis=</a><spanlang=3DEN-GB><o:p></o:p></h2>


FSANZ is required to consider the impa=ct ofvarious regulatory (and non-regulatory) options on all sectors of thecommunity, which includes consumers, food industry and governments in <st1:=country-regionw:st=3D"on">Australia</st1:country-region> and <st1:place w:st=3D"on"><st1:=country-region w:st=3D"on">New Zealand</st1:country-region></st1:place>.<spanstyle=3D'mso-spacerun:yes'> The benefits and costs associated =withproposed amendments to the Code will be analysed using regulatory impactprinciples.<o:p></o:p>

<o:p> </o:p>

<a name=3D"_Toc120358588="><spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>Following stakeholderconsultation on the Initial Consideration of this Proposal, no immediate co=stsfrom the proposed variation to clause 27 on affected parties wereidentified. <o:p></o:p></span=></a>


<spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>However, it was considere=d likelythat there would be potential benefits for all affected parties throughproviding regulatory clarity, and in turn maintaining the supply and availa=bilityof special purpose infant formula. Re-consideration of the issue through this Assessment Report allows =theimpact of the urgent amendment to be given further consideration prior to f=inalapproval. <o:p></o:p>

<spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'><o:p> </o:p><=/span>

<h3><a name=3D"_Toc208208616"><s=panlang=3DEN-GB>6.1 &nb=sp; AffectedParties</a><o:p></o:p></h3>


Thosepotentially affected by the above options include:<o:p></o:p>


<spanlang=3DEN-GB>1. &nbs=p; infantswith certain medical conditions and their carers, as well as the healthprofessionals supervising their medical care;

<spanlang=3DEN-GB><o:p> </o:p>

<spanlang=3DEN-GB>2. &nbs=

p; manufacturersand importers of special purpose infant formulas; and

<spanlang=3DEN-GB><o:p> </o:p>

<spanlang=3DEN-GB>3. &nbs=p; State/Territory,Australian and <st1:place w:st=3D"on"><st1:country-region w:st=3D"on">New Z=ealand</st1:country-region></st1:place>Governments.<o:p></o:p>


<h3><a name=3D"_Toc163372735"></a><a name=3D"_Toc176607453"></a><aname=3D"_Toc176936961"></a><a name=3D"_Toc178051345"></a><a name=3D"_Toc186=002875"></a><aname=3D"_Toc204594539"></a><a name=3D"_Toc208208617">6.2<spanstyle=3D'mso-tab-count:1'> =BenefitCost Analysis</a><spanlang=3DEN-GB> <o:p></o:p></h3>

<o:p>= </o:p>

This Benefit Cost Analysis assesses= theimmediate and potential impacts of each regulatory option on the affectedparties.<o:p></o:p>


<h4 style=3D'mso-pagination:widow-orphan lines-together'>6.2.1<spanstyle=3D'mso-tab-count:1'> Option 1 &#=8211; <spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>re-affirm the amendment m=ade toclause 27 of Standard 2.9.1 <o:p></o:p></h=4>

<h4 style=3D'mso-pagination:widow-orphan lines-together'><o:p> </o:p></h4>

<h5>6.2.1.1 =Consumers<o:p></o:p></h5>

<h5 style=3D'margin-left:0cm;text-indent:0cm;mso-pagination:widow-orphan li=nes-together'><spanlang=3DEN-GB><o:p> </o:p><=/span></h5>

Reaffirming the variation made to <=

/span><spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>clause 27 of Standard 2.9=.1<spanlang=3DEN-GB> would maintain the availability of certain special purpose infant formula to infants wi=thspecific medical conditions in <st1:country-region w:st=3D"on">Australia</s=t1:country-region>and <st1:place w:st=3D"on"><st1:country-region w:st=3D"on">New Zealand</st1=:country-region></st1:place>,thus protecting their health and safety. <o:p></o:p>


<h5>6.2.1.2 =Industry<o:p></o:p></h5>


Maintaining the status quo through reaffirming the amendment made to clause 27would provide clarity for industry, and enable manufacturers to continue toproduce special purpose infant formula without the potential for enforcementaction. <o:p></o:p>

<h5><o:p> </sp=an></o:p></h5>

<h5>6.2.1.3 =Government<o:p></o:p></h5>


Option 1 would maintain clarity regard=ingthe regulatory status of these special purpose products and avoid the need =forunnecessary enforcement action. <o:p></o:p>

<o:p> =</o:p>

<istyle=3D'mso-bidi-font-style:normal'>6.2.2 =Option2 – prepare a new (separate) proposal which may result in the amendme=ntsmade to clause 27 of Standard 2.9.1 being varied or replaced.<sp=anlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'><spanstyle=3D'mso-spacerun:yes'> <spanstyle=3D'mso-spacerun:yes'> <o:p></o:p>

<o:p> =</o:p>

Under Option 2 the amendments made to =clause27 of Standard 2.9.1 would remain in place as gazetted on 30 June 2008, unt=ilthe issue is fully considered by a new proposal.<spanstyle=3D'mso-spacerun:yes'> Consequently, in the interim, theimpacts would be similar to Option 1. <spanstyle=3D'mso-spacerun:yes'> The impact of any proposed change orreplacement of the amendment to clause 27 would be considered as part of a =newseparate proposal once prepared. <o:p></o:p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:12.0pt;font=-family:Arial;mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'> 


<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;background:#CCCCCC'>

=Questionsfor submitters: <o:p></o:p>

<spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'><o:p> </o:p><=/p>

Hav=e theamendments to clause 7 of Standard 2.9.1 made using the urgency provisions =ofthe FSANZ Act and gazetted on 30 June 2008 resolved the issue/problem (asdescribed in section 2) for all affected parties?<o:p></o:p>

Are= there anyunforeseen unintended consequences or unresolved issues resulting from theamendments made to clause 7 of Standard 2.9.1 which would require furtherconsideration through preparation of a new (separate) proposal?<o:p></o:p><=/span>

<o:=p> </o:p>

Is =

there anyevidence to suggest that the amendments made to clause 7 of Standard 2.9.1 =needto be varied or replaced?<o:p></o:p>

</div>


<h2><a name=3D"_Toc11735640"></a><a name=3D"_Toc29883125"></a><a name=3D"_T=oc41906812"></a><aname=3D"_Toc41907559"></a><a name=3D"_Toc120358593"></a><a name=3D"_Toc2082=08618"><spanstyle=3D'mso-bookmark:_Toc120358593'><spanstyle=3D'mso-bookmark:_Toc41906812'><spanstyle=3D'mso-bookmark:_Toc11735640'>7. Consultation</s=pan></a><spanlang=3DEN-GB><o:p></o:p></h2>


At Initial Consideration FSANZ, havingdeclared this Proposal urgent under section 95 of the FSANZ Act conducted s=ixbusiness days (seven business days in <st1:State w:st=3D"on">Western Austra=lia</st1:State>and <st1:country-region w:st=3D"on"><st1:place w:st=3D"on">New Zealand</st1=:place></st1:country-region>)of public consultation. <o:p>=</o:p>


During that consultation period of 6-1=7 June2008, FSANZ received 10 submissions (see Attachment 2).<spanstyle=3D'mso-spacerun:yes'> All submitters supported making theproposed urgent amendment to the Code.&nbs=p;<o:p></o:p>


Key issues arising from submissionsincluded:<o:p></o:p>

<o:p> </o:p>

<![if !supportLists]>· &nbsp=; <![endif]>FSANZ’s proposed fu=tureplan for considering the regulation of special purpose infant formula in thelonger term. Whilst noting th=atdevelopment of relevant Ministerial policy guidance is underway, mostsubmitters supported progression of this future work as a priority onceMinisterial policy guidelines are received by FSANZ;<o:p></o:p>

<o:p> </o:p>

<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>the need to progress Prop=osalP242 – Food for Special Med=icalPurposes, including definitions of the purpose of the products, thelevel of evidence required for claims on these products, access to theseproducts, uncertainty over compositional specifications and indiscriminateaddition of ingredients. Theseissues will be considered under Proposal P242 following completion of the<s=panstyle=3D'mso-spacerun:yes'> Ministerial policy guidelines on t=heintent of Part 2.9 – Special Purpose Foods; and <o:p></o:p>

<o:p> </o:p>

<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>concern that action to am=endclause 27 of Standard 2.9.1 was not initiated until after the commencementclause came into effect and that other similar clauses may exist in the Code<spanlang=3DEN-GB>. In response, F=SANZ hasundertaken an audit of the Code and no other clauses require attention in amanner which gave rise to this urgent Proposal.<o:p></o:p>


FSANZ isnow seeking public comment in order to assist the reconsideration of theresulting variation made following Initial Consideration of ProposalP1006. <o:p></o:p>

<o:p> </o:p>

<h3><a name=3D"_Toc15456903"></a><a name=3D"_Toc20727764"></a><a name=3D"_T=oc29727729"></a><aname=3D"_Toc29883126"></a><a name=3D"_Toc41906813"></a><a name=3D"_Toc41907=560"></a><aname=3D"_Toc120358594"></a><a name=3D"_Toc208208619">7.1 &=nbsp; WorldTrade Organization (WTO)</=span></a><spanlang=3DEN-GB><o:p></o:p></h3>

<o:p> </o:p>

As members of the World Trade Organ=ization(WTO), <st1:country-region w:st=3D"on">Australia</st1:country-region> and <=st1:placew:st=3D"on"><st1:country-region w:st=3D"on">New Zealand</st1:country-region=></st1:place>are obligated to notify WTO member nations where proposed mandatory regulat=orymeasures are inconsistent with any existing or imminent international stand=ardsand the proposed measure may have a significant effect on trade.<o:p></o:p>=



There are relevant international st=andardsand retaining the amendment to the Code to provide permissions for specialpurpose infant formulas as proposed, would ensure continued international t=radeand imports to the Australian and New Zealand market, thereby protecting thepublic health and safety of infants who rely on these products for theirparticular nutritional requirements. <o:p></o:p>


As it is not =expectedthat this approach will result in a potential barrier to trade, WTO member

nations have not been notified of the amendment to Standard 2.9.1 under eit=herthe Technical Barriers to Trade or Sanitary and Phytosanitary Agreements.<o=:p></o:p>


<h2><a name=3D"_Toc208208620">8. Conclusionand Preferred Option</a> <o:p></o:p></h2>


<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

Preferred Option:<o:p></o:p><=/span>

<o:p> </o:p>

FSANZ’spreferred approach is to re-affirm the amendment made to clause 27 of Stand=ard2.9.1 – Infants Formula Products that removed the commencement provis=ion(subclause 27(3) and consequentially removed subclause 27(2)).<o:p></o:p></=span>

</div>

<spanlang=3DEN-GB style=3D'font-size:14.0pt'><o:p> </o:p>

<h3><a name=3D"_Toc208208621">8.1 Reasons for Deci=sion</a><spanstyle=3D'mso-bookmark:_Toc208208621'><o:p></o:p></h3>


FSANZ is recommending the amendment= made toclause 27 of Standard 2.9.1 (see Attachment 1) be re-affirmed as it provide=s netbenefits to all affected parties. This is because the amendment:<o:p></o:p>


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>retains the <istyle=3D'mso-bidi-font-style:normal'>status quo approach to permitting =

infantformulas to be specifically formulated to satisfy particular metabolic,immunological, renal, hepatic and malabsorptive conditions;<o:p></o:p></spa=n>


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>protects the public healt=h andsafety of infants with particular nutritional requirements by ensuring that= theavailability and supply of special purpose infant formulas in <st1:country-=regionw:st=3D"on">Australia</st1:country-region> and <st1:country-region w:st=3D"=on"><st1:place w:st=3D"on">New Zealand</st1:place></st1:country-region> is not unduly hin=dered;and <o:p></o:p>


<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]>provides certainty for co=nsumers,industry and enforcement agencies on the regulatory status of special purpo=seinfant formula.<o:p></o:p>


<spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>The preferred option woul=d retainthe variation to clause 27 of Standard 2.9.1 which came into effect at gaze=ttalon 30 June 2008. <o:p></o:p>

<a name=3D"_Toc11735643"></a><a name=3D"_Toc29883130">=</a><aname=3D"_Toc41906817"></a><a name=3D"_Toc41907564"></a><a name=3D"_Toc43112=360"><spanstyle=3D'mso-bookmark:_Toc41907564'><spanstyle=3D'mso-bookmark:_Toc29883130'><spanlang=3DEN-GB><o:p> </o:p></a>

<spanstyle=3D'mso-bookmark:_Toc41907564'><spanstyle=3D'mso-bookmark:_Toc29883130'>ATTACHMENT<s=panlang=3DEN-GB style=3D'font-size:14.0pt;mso-bidi-font-size:12.0pt;mso-bidi-f=ont-family:Arial'>S<o:p></o:p>


1.<s=panstyle=3D'mso-tab-count:1'> Varia=tionto the Australia New Zealand FoodStandards Code as gazetted on 30 June 2008

2.&=nbsp; Summaryof Submissions received following Initial Consideration<o:p></o:p></=p>

<span lang=3DEN-GB style=3D'font-size:14.0pt;font-family:Arial;mso-fareast-=font-family:"Arial Unicode MS";mso-bidi-font-family:"Arial Unicode MS";mso-ansi-languag=e:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'> 

<h2 align=3Dright style=3D'text-align:right'><a name=3D"_Toc120358597"></a>=<aname=3D"_Toc208208622">Attachment 1</a><spanstyle=3D'mso-bookmark:_Toc120358597'><o:p></o:p></h2>

<o:p> </o:p>

<h2 style=3D'margin-left:0cm;text-indent:0cm'><aname=3D"_Toc208208623">Variationto the </a><spanstyle=3D'mso-bookmark:_Toc208208623'><spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>Australia New Zealand FoodStandards Code<istyle=3D'mso-bidi-font-style:normal'> <spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial;mso-bidi-font-style:normal='>asgazetted on 30 June 2008<spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'><o:p></o:p></h2>

<o:p> </o=:p>

<istyle=3D'mso-bidi-font-style:normal'>Subsection 87(8) of the FSANZ Act provides that standards or variati=onsto standards are legislative instruments, but are not subject to disallowan=ceor sunsetting<o:p></o:p>

<o:p> </o:p>

[1]<spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'> =Standard2.9.1 of the <st1:country-region w:st=3D"on">Australia</st1:coun=try-region><st1:place w:st=3D"on"><st1:country-region w:st=3D"on">New Zealand</st1:cou=ntry-region></st1:place>Food Standards Code is varied by omittingclause 27, substituting &#8=211;<spanlang=3DEN-GB style=3D'font-size:12.0pt;mso-bidi-font-size:10.0pt;mso-bidi-f=ont-family:Arial'><o:p></o:p>


27<spanstyle=3D'mso-tab-count:1'> &=nbsp; Composition<o:p></o:p>


I=nfantformula products may be specifically formulated to satisfy particularmetabolic, immunological, renal, hepatic or malabsorptive conditions provid=edthat in all other respects the products comply with this Division.<o:p></o:=p>

<spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'><o:p> </o:p><=/p>

<span lang=3DEN-GB style=3D'font-size:14.0pt;font-family:Arial;mso-fareast-=font-family:"Arial Unicode MS";mso-bidi-font-family:"Arial Unicode MS";mso-ansi-languag=e:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'> 



<h2 align=3Dright style=3D'text-align:right'><a name=3D"_Toc201554455"></a>=<aname=3D"_Toc208208624">Attachment 2</a><spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'><o:p></o:p></h2>


<h2><a name=3D"_Toc201554456"></a><a name=3D"_Toc208208625">P1006 – Summary of Submissions at I=nitialConsideration</a><o:p></o:p></h2>


At Initial Consideration FSANZ, havingdeclared Proposal P1006 urgent under section 95 of the FSANZ Act conducted =sixbusiness days (seven business days in <st1:State w:st=3D"on">Western Austra=lia</st1:State>and <st1:place w:st=3D"on"><st1:country-region w:st=3D"on">New Zealand</st1=:country-region></st1:place>)of public consultation. </spa=n><spanlang=3DEN-GB style=3D'font-size:12.0pt;mso-bidi-font-family:Arial'><o:p></o=:p>


Two regulatory options for Proposal= P1006were presented at Initial Consideration, namely: <o:p></o:p>

<o:p> </o:p>

<![if !supportLists]><s=panlang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=-bidi-font-family:Symbol'>· &nb=sp; <![endif]><spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>Option 1 -<spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'> donothing; or<o:p></o:p>

<o:p> </o:p>

<![if !supportLists]><spanstyle=3D'mso-list:Ignore'>· &nbsp=; <![endif]><spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>Option 2 -<spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'> amendclause 27 of Standard 2.9.1 to remove the commencement provision <sp=anlang=3DEN-GB>(subclause 27(3) and a consequent removal of subclause 27(2)) =<spanlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'>thereby restoring the pre=vious <istyle=3D'mso-bidi-font-style:normal'>status quo approach to permitting =infantformulas to be specifically formulated to satisfy particular metabolic,immunological, renal, hepatic and malabsorptive conditions.<o:p></o:p></spa=n>

<sp=anlang=3DEN-GB style=3D'mso-bidi-font-family:Arial'><o:p> </o:p><=/p>

Duringthe consultation period of 6-17 June 2008, FSANZ received 10 submissions. <=/span><spanlang=3DEN-GB>A summary of submitter comments is provided in the following t=able.<o:p></o:p>

<o:p> </o:p>

<table border=3D0 cellspacing=3D0 cellpadding=3D0 style=3D'border-collapse:=collapse; mso-yfti-tbllook:480;mso-padding-alt:0cm 5.4pt 0cm 5.4pt'> <thead> <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'> <td width=3D43 valign=3Dtop style=3D'width:32.4pt;border:solid windowtex=t 1.0pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> No.<o:p><=/o:p> </td> <td width=3D167 valign=3Dtop style=3D'width:125.55pt;border:solid window=text 1.0pt; border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=t: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Submitter=<o:p></o:p> </td>

<td width=3D406 valign=3Dtop style=3D'width:304.15pt;border:solid window=text 1.0pt; border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=t: solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Comment<o=:p></o:p> <o:p>&nbs=p;</o:p> </td> </tr> </thead> <tr style=3D'mso-yfti-irow:1'> <td width=3D616 colspan=3D3 valign=3Dtop style=3D'width:462.1pt;border:so=lid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=olid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> Industry<o=:p></o:p> </td> </tr> <tr style=3D'mso-yfti-irow:2'> <td width=3D43 valign=3Dtop style=3D'width:32.4pt;border:solid windowtext= 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=olid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> 1.<o:p></o:p> </td> <td width=3D167 valign=3Dtop style=3D'width:125.55pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Australian Food and Grocery Council<o:p></o:p> </td> <td width=3D406 valign=3Dtop style=3D'width:304.15pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Supports Option 2 – amend clause 27.<o:p></o:p> <o:p> </o:p> Suggests that as FSANZ did not initiate action until after the ‘sunset clause’ came into effect there is need for review of internal procedures by FSANZ. Agrees with urgency as allowing circumstances that risk continuati=on of supply, and the unnecessary technical breach in supplying such products should not be permitted.<o:p></o:p> <o:p> </o:p> </td> </tr> <tr style=3D'mso-yfti-irow:3'> <td width=3D43 valign=3Dtop style=3D'width:32.4pt;border:solid windowtext= 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=olid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> 2.<o:p></o:p> </td> <td width=3D167 valign=3Dtop style=3D'width:125.55pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Food Technology Association of <st1:place w:st=3D"on"><st1:country=-region w:st=3D"on">Australia</st1:country-region></st1:place><o:p></o:p>= </td> <td width=3D406 valign=3Dtop style=3D'width:304.15pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Supports Option 2 – amend clause 27.<o:p></o:p> <o:p> </o:p> Raises concern that the “grey area” between foods and =medicine is being ignored given these products maybe available on prescription and subsided under Australian or NZ pharmaceutical benefit/schedule schemes.<=o:p></o:p> <o:p> </o:p> Expresses concern over the delay in finalising Proposal P242 &#821=1; Foods for Special Medical Purposes and suggests this also attracts urgent

attention. <o:p></o:p> <o:p> </o:p> </td> </tr> <tr style=3D'mso-yfti-irow:4'> <td width=3D43 valign=3Dtop style=3D'width:32.4pt;border:solid windowtext= 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=olid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> 3.<o:p></o:p> </td> <td width=3D167 valign=3Dtop style=3D'width:125.55pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Nutricia <st1:place w:st=3D"on"><st1:country-region w:st=3D"on">Au=stralia</st1:country-region></st1:place><o:p></o:p> <o:p> </o:p> </td> <td width=3D406 valign=3Dtop style=3D'width:304.15pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Supports Option 2 – amend clause 27.<o:p></o:p> </td> </tr> <tr style=3D'mso-yfti-irow:5'> <td width=3D43 valign=3Dtop style=3D'width:32.4pt;border:solid windowtext= 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=olid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> 4.<o:p></o:p> </td> <td width=3D167 valign=3Dtop style=3D'width:125.55pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Wyeth <st1:place w:st=3D"on"><st1:country-region w:st=3D"on">Austr=alia</st1:country-region></st1:place><o:p></o:p>

</td> <td width=3D406 valign=3Dtop style=3D'width:304.15pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Supports Option 2 – amend clause 27.<o:p></o:p> <o:p> </o:p> Comments that the intended purpose of infant formula for special d=ietary use provides no clear definition so that there is a risk of misinterpreta=tion of suitability. The level of evidence required for claims on these products is not stipulated leading =to a significant risk to public health and safety. <o:p></o:p> <o:p> </o:p> <o:p> </o:p> <o:p> </o:p> The current Proposal may allow for direct promotion to a consumer which is inconsistent with use under medical supervision.<o:p></o:p></spa=n> <o:p> </o:p> </td> </tr> <tr style=3D'mso-yfti-irow:6'> <td width=3D616 colspan=3D3 valign=3Dtop style=3D'width:462.1pt;border:so=lid windowtext 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=olid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> Government=<o:p></o:p> </td> </tr> <tr style=3D'mso-yfti-irow:7'> <td width=3D43 valign=3Dtop style=3D'width:32.4pt;border:solid windowtext= 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=olid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> 5.<o:p></o:p> </td> <td width=3D167 valign=3Dtop style=3D'width:125.55pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Department of Health, <st1:place w:st=3D"on"><st1:State w:st=3D"on=">Western Australia</st1:State></st1:place><o:p></o:p> </td> <td width=3D406 valign=3Dtop style=3D'width:304.15pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Supports Option 2 – amend clause 27 (on condition that a ful=l review of the decision is conducted within 12 months).<o:p></o:p> <o:p> </o:p> Considers that there should be improved controls in accessing these products as it is aware that these products, although for use under medic=al supervision, are freely available in the marketplace. Assumes this will be considered as part of ministerial policy guidance development. The policy guidelines for infant formula should be progressed as a matter of priority.<o:p></o:p></=p> <o:p> </o:p> </td> </tr> <tr style=3D'mso-yfti-irow:8;page-break-inside:avoid'> <td width=3D43 valign=3Dtop style=3D'width:32.4pt;border:solid windowtext= 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=olid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> 6.<o:p></o:p> </td> <td width=3D167 valign=3Dtop style=3D'width:125.55pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Department of Health, <st1:place w:st=3D"on"><st1:State w:st=3D"on=">South Australia</st1:State></st1:place><o:p></o:p> </td> <td width=3D406 valign=3Dtop style=3D'width:304.15pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Supports Option 2 – amend clause 27.<o:p></o:p> <o:p> </o:p> Agrees that the regulation, particularly the compositional specifications should be re-considered as part of the proposed infant for=mula standard review. Agrees tha=t the review should await Ministerial Council policy guidance but supports expediting the review as soon as possible. <o:p></o:p> <o:p> </o:p> </td> </tr> <tr style=3D'mso-yfti-irow:9;page-break-inside:avoid'> <td width=3D43 valign=3Dtop style=3D'width:32.4pt;border:solid windowtext= 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=olid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> 7.<o:p></o:p> </td> <td width=3D167 valign=3Dtop style=3D'width:125.55pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Department of Human Services, <st1:place w:st=3D"on"><st1:State w:=st=3D"on">Victoria</st1:State></st1:place><o:p></o:p> </td> <td width=3D406 valign=3Dtop style=3D'width:304.15pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Supports Option 2 – amend clause 27.<o:p></o:p> <o:p> </o:p> Recognises that the review of infant formula standard and progress= on related work (Proposal P242 – Foods for Special Medical Purposes) i=s dependent on the policy development work under-way.<o:p></o:p> <o:p> </o:p> </td> </tr> <tr style=3D'mso-yfti-irow:10'> <td width=3D43 valign=3Dtop style=3D'width:32.4pt;border:solid windowtext= 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=olid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> 8.<o:p></o:p> </td> <td width=3D167 valign=3Dtop style=3D'width:125.55pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> NSW Food Authority<o:p></o:p> </td> <td width=3D406 valign=3Dtop style=3D'width:304.15pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Supports Option 2 – amend clause 27.<o:p></o:p> <o:p> </o:p> Urges FSANZ to expedite development of an appropriate standard, no=ting that progress is contingent on ministerial policy guidance. Considers that both the proposed= and existing standard are vague, particularly in regards to the possible indiscriminate addition of ingredients, additives and nutrients not other=wise permitted in the infant formula standard which creates substantial uncert=ainty. Is concerned that the standard d=oes not prevent sale of these products without medical supervision and that availability on prescription does not provide a safeguard against

inappropriate use.<o:p></o:p> <o:p> </o:p> </td> </tr> <tr style=3D'mso-yfti-irow:11'> <td width=3D43 valign=3Dtop style=3D'width:32.4pt;border:solid windowtext= 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=olid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> 9.<o:p></o:p> </td> <td width=3D167 valign=3Dtop style=3D'width:125.55pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <st1:place w:st=3D"on"><st1:country-region w:st=3D"o=n">New =Zealand</st1:country-region></st1:place> Food =Safety Authority (NZFSA)<o:p></o:p> </td> <td width=3D406 valign=3Dtop style=3D'width:304.15pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Supports Option 2 – amend clause 27.<o:p></o:p> <o:p> </o:p> In regards to future work, NZFSA strongly supports progression of =work on the regulation of special purpose infant formula outside work on Propo=sal P242 – Foods for Special Medical Purposes. <o:p></o:p> <o:p> </o:p> </td> </tr> <tr style=3D'mso-yfti-irow:12;mso-yfti-lastrow:yes'> <td width=3D43 valign=3Dtop style=3D'width:32.4pt;border:solid windowtext= 1.0pt; border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=olid windowtext .5pt; padding:0cm 5.4pt 0cm 5.4pt'> 10.<o:p></o:p> </td> <td width=3D167 valign=3Dtop style=3D'width:125.55pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> <st1:place w:st=3D"on"><st1:State w:st=3D"on">Quee=nsland</st1:State></st1:place> Healt=h<o:p></o:p> </td> <td width=3D406 valign=3Dtop style=3D'width:304.15pt;border-top:none;bord=er-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=.0pt; mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=text .5pt; mso-border-alt:solid windowtext .5pt;padding:0cm 5.4pt 0cm 5.4pt'> Supports Option 2 – amend clause 27.<o:p></o:p> <o:p> </o:p> Considers that the proposed future action (review of infant formula standard and re-commencement of work on Proposal P242 – Foods for Special Medical Purposes) needs to be progressed as a matter of priority.=<o:p></o:p> <o:p> </o:p> </td> </tr></table>

<h2 align=3Dright style=3D'text-align:right'><o:p> =</o:p></h2>

</div>

<div style=3D'mso-element:footnote-list'><![if !supportFootnotes]> 

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]>

<div style=3D'mso-element:footnote' id=3Dftn1>

<a style=3D'mso-footnote-id:ftn1' href=3D"#_ftnr=ef1"name=3D"_ftn1" title=3D""><spanstyle=3D'mso-special-character:footnote'><![if !supportFootnotes]><spanclass=3DMsoFootnoteReference><span lang=3DEN-GB style=3D'font-size:10.0pt;f=ont-family:Arial;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:"Times= New Roman";

mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'=>[1]<![endif]></a><spanlang=3DEN-GB> ‘specialpurpose infant formula’ in this Report means ‘infant formulaproducts specifically formulated to satisfy particular metabolic,immunological, renal, hepatic and malabsorptive conditions’.<o:p></o:=p>

</div>


<a style=3D'mso-footnote-id:ftn2' href=3D"#_ftnr=ef2"name=3D"_ftn2" title=3D""><spanstyle=3D'mso-special-character:footnote'><![if !supportFootnotes]><spanclass=3DMsoFootnoteReference><span lang=3DEN-GB style=3D'font-size:10.0pt;f=ont-family:Arial;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:"Times= New Roman";mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'=>[2]<![endif]></a><spanlang=3DEN-GB> ‘specialpurpose infant formula’ in this Report means ‘infant formulaproducts specifically formulated to satisfy particular metabolic,immunological, renal, hepatic and malabsorptive conditions.<o:p></o:p></spa=n>

</div>


<a style=3D'mso-footnote-id:ftn3' href=3D"#_ftnr=ef3"name=3D"_ftn3" title=3D""><spanstyle=3D'mso-special-character:footnote'><![if !supportFootnotes]><spanclass=3DMsoFootnoteReference><span lang=3DEN-GB style=3D'font-size:10.0pt;f=ont-family:Arial;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:"Times= New Roman";mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'=>[3]<![endif]></a><spanlang=3DEN-GB> PharmaceuticalBenefits Scheme as administered by the Australia Government.<spanlang=3DEN-US style=3D'mso-ansi-language:EN-US'><o:p></o:p>

</div>


<a style=3D'mso-footnote-id:ftn4' href=3D"#_ftnr=ef4"name=3D"_ftn4" title=3D""><spanstyle=3D'mso-special-character:footnote'><![if !supportFootnotes]><spanclass=3DMsoFootnoteReference><span lang=3DEN-GB style=3D'font-size:10.0pt;f=ont-family:Arial;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:"Times= New Roman";

mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'=>[4]<![endif]></a><spanlang=3DEN-GB> NZ Pharmaceutical Schedule, administered by PHARMAC (thePharmaceutical Management Agency Ltd).<o:p></o:p>

</div>

</div>

</body>

</html>

------=_NextPart_01C9119B.74EB4AB0Content-Location: file:///C:/E328C6E5/P1006_files/header.htmContent-Transfer-Encoding: quoted-printableContent-Type: text/html; charset="us-ascii"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"xmlns:o=3D"urn:schemas-microsoft-com:office:office"xmlns:w=3D"urn:schemas-microsoft-com:office:word"xmlns:st1=3D"urn:schemas-microsoft-com:office:smarttags"xmlns=3D"http://www.w3.org/TR/REC-html40">

<head><meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dus-ascii"><meta name=3DProgId content=3DWord.Document><meta name=3DGenerator content=3D"Microsoft Word 11"><meta name=3DOriginator content=3D"Microsoft Word 11"><link id=3DMain-File rel=3DMain-File href=3D"../P1006.htm"><![if IE]><base href=3D"file:///C:\E328C6E5\P1006_files\header.htm"id=3D"webarch_temp_base_tag"><![endif]><o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags" name=3D"place"=/><o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags" name=3D"country-region"/><o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags" name=3D"State"/><o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags" name=3D"City"/></head>

<body lang=3DEN-AU link=3D"#000000" vlink=3Dpurple>

<div style=3D'mso-element:footnote-separator' id=3Dfs>

<![if !supportFootnotes]>


<![endif]>

</div>

<div style=3D'mso-element:footnote-continuation-separator' id=3Dfcs>

<![if !supportFootnotes]>

<hr align=3Dleft size=3D1>


</div>

<div style=3D'mso-element:endnote-separator' id=3Des>

<![if !supportFootnotes]>



</div>

<div style=3D'mso-element:endnote-continuation-separator' id=3Decs>

<![if !supportFootnotes]>

<hr align=3Dleft size=3D1>


</div>

<div style=3D'mso-element:footer' id=3Def1>

<div style=3D'mso-element:frame;mso-element-wrap:around;mso-element-anchor-=vertical:paragraph;mso-element-anchor-horizontal:margin;mso-element-left:center;mso-element-top:.05pt;mso-height-rule:exactly'>

<table cellspacing=3D0 cellpadding=3D0 hspace=3D0 vspace=3D0 align=3Dcenter> <tr> <td valign=3Dtop align=3Dleft style=3D'padding-top:0cm;padding-right:0cm; padding-bottom:0cm;padding-left:0cm'> <p class=3DMsoFooter style=3D'mso-element:frame;mso-element-wrap:around; mso-element-anchor-vertical:paragraph;mso-element-anchor-horizontal:margi=n; mso-element-left:center;mso-element-top:.05pt;mso-height-rule:exactly'><!=--[if supportFields]>PAGE <![endif]--><o:p></o:p> </td> </tr></table>

</div>

<o:p> </o:p>

</div>

<div style=3D'mso-element:footer' id=3Df1>

<div style=3D'mso-element:frame;mso-element-wrap:around;mso-element-anchor-=vertical:paragraph;mso-element-anchor-horizontal:margin;mso-element-left:center;mso-element-top:.05pt;mso-height-rule:exactly'>

<table cellspacing=3D0 cellpadding=3D0 hspace=3D0 vspace=3D0 align=3Dcenter> <tr> <td valign=3Dtop align=3Dleft style=3D'padding-top:0cm;padding-right:0cm; padding-bottom:0cm;padding-left:0cm'> <p class=3DMsoFooter style=3D'mso-element:frame;mso-element-wrap:around; mso-element-anchor-vertical:paragraph;mso-element-anchor-horizontal:margi=n; mso-element-left:center;mso-element-top:.05pt;mso-height-rule:exactly'><s=pan class=3DMsoPageNumber>ii</sp=an><o:p></o:p> </td> </tr></table>

</div>

<o:p> </o:p>

</div>

<div style=3D'mso-element:header' id=3Dfh1>

BOARD-IN-CONFIDENCE<o:p></o:p>

</div>

</body>

</html>

------=_NextPart_01C9119B.74EB4AB0Content-Location: file:///C:/E328C6E5/P1006_files/image001.pngContent-Transfer-Encoding: base64Content-Type: image/png

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

fJ9XFa128EjLEfEf80cTtAEWHz/i+5oeyEqJvFDSSntPpVjd6+05efsCX950lBS3Oz0MHk/AvkSORwcACHwQCN2+WaOnFBpldIrS5AkBNYG77SH6gHjclqKdqylNTpiF/G9+RjK3UkqD/WtAOmFSjmrTn9YKyKqp+Rrvwt2v0uqc3Sf/cS24LKaTv1oIK5uOoU8aFVc5Ma8jUHDBr4ODJwioCDhv5SxOFf02g53LiLcr2lQGiRxP4MvmsPSE+L4tLXW+Vvd9kJfk2Ty9JQwfnXxbKo1Xyn7WayJYt/lVWpyVYvWvE+fsFzUdvZ8u/LlisTUBTsPW8pLcJgJzGzurcpNs2dxSRtkUIR4IQAACEIAABCAAAQh4EVjQdJx7oPBKFDtHE6C9cbT8JL+AgGijZyEuUKK2C0kdUUa1NSZ6CEAAAhCAAAQgAIGDCAQ3HSXPDwfRJtVNBHhG3QQetxCAAAQgAAEIQAACEIAABCAAAQgcSiCu6Ui/8dCSypg2TceMqhATBCAAAQhAAAIQgAAEIAABCEAAAn0JxDQdaTj2rZiKmdFzrKgaMUMAAhCAAAQgAAEIQAACEIAABCBQmEBA05GOY+F66Bk6TceeupIVBCAAAQhAAAIQgAAEIAABCEAAAmkJODcdaTimVfrgwOg5Hiw+qUMAAhCAAAQgAAEIQAACEIAABCCwhYBj05GG4xYFcTokQNNxiIgBEIAABCAAAQhAAAIQgAAEIAABCEDAlYBX05GOo6ssGHMkQM/RESamIAABCEAAAhCAAAQgAAEIQAACEICAhIBH05GGo4Q0Y3YRoOm4izx+IQABCEAAAhCAAAQgAAEIQAACEDiWwHTTkY7jXe1873VBas8qo+e4hzteIQABCEAAAhCAAAQgAAEIQAACEDiZwHTT8Re9tJ/1c9/ngtbq1UbPcTVx/EEAAhCAAAQgAAEIQAACEIAABCAAgV80Hd2LYNTlou/ojvzJ4EiOpcHgDAIQgAAEIAABCEAAAhCAAAQgAAEInEFgvunIq46fK0XW4qLvuGx1yQRZFg6OIAABCEAAAhCAAAQgAAEIQAACEIDAEQQcmo50Hf9WirzDRdtx0fKSS7IoINxAAAIQgAAEIAABCEAAAhCAAAQgAIEDCNB09BNZ19+i7ehH/t6STpMVEeEDAhCAAAQgAAEIQAACEIAABCAAAQgcQMCj6cirjq+Fom9v0XaMX2B6VeJjwgMEIAABCEAAAhCAAAQgAAEIQAACEGhPgKajj8S25hZtRx/6t1ZssgQHhXkIQAACEIAABCAAAQhAAAIQgAAEINCewP88MqS1YyRgnOahGTYgAAEIQAACEIAABCAAAQhAAAIQgAAEIBBFwOVNx9O/Xz3TO+Rlx6jSfrE7I0xgWJiGAAQgAAEIQAACEIAABCAAAQhAAALdCbi86Xh4c2eqtTU1uXt1TuYH20mATIcABCAAAQhAAAIQgAAEIAABCEAAAkYCPk3Ho7uOk62tyelG3ZkGAQhAAAIQgAAEIAABCEAAAhCAAAQgAIEwAk5Nx7D40hv+b7ppOG0gPaNNAQJ2E3jcQgACEIAABCAAAQhAAAIQgAAEIAABr6bjqQ0ej7zn+5bUMQQgAAEIQAACEIAABCAAAQhAAAIQgAAEEhHwajomSmllKB49x5d4ncyszDy/L6Dm14gIIQABCEAAAhCAAAQgAAEIQAACEOhKwK3peGSLxy1pN0Nd61SfF0j1zJgBAQhAAAIQgAAEIAABCEAAAhCAAAScCLg1HU98W4++llMVYgYCEIAABCAAAQhAAAIQgAAEIAABCECgFQG/pmMrLKJkPHuOnrZEwXcfBNDuCpMfBCAAAQhAAAIQgAAEIAABCEAAApkJODYdafPMCA29GXo/5oLTFSfGIAABCEAAAhCAAAQgAAEIQAACEICAjoBj0/G0L1g797WczenKgNEQgAAEIAABCEAAAhCAAAQgAAEIQAACEPAj4Nl09IuqgiX3JqG7wQoUg2KEZRBYzEIAAhCAAAQgAAEIQAACEIAABCAAAREB16bjSa2ek3IVVRKDIAABCEAAAhCAAAQgAAEIQAACEIAABCDwh4Br0xGqUwToY07h+zQZkl4ksQMBCEAAAhCAAAQgAAEIQAACEIAABEwEfJuO5zR7QjINMWoqi9qT4FhbP6KHAAQgAAEIQAACEIAABCAAAQhAoD4B36bjMX9LhrZW/dInAwhAAAIQgAAEIAABCEAAAhCAAAQgAIEoAs5Nx6gwD7FLL9NDaCh6UMQGBCAAAQhAAAIQgAAEIAABCEAAAhCYIODddDyj4XNGlhNltXMq4uykj28IQAACEIAABCAAAQhAAAIQgAAEIPBKwLvpeMwXrGPKh4ZZDFesQgACEIAABCAAAQhAAAIQgAAEIAABCKwk4N50XBn8Ll+0BneRF/hFHAEkhkAAAhCAAAQgAAEIQAACEIAABCAAgVgC/k1Hmj4zikFvht7LXABOAmQ6BCAAAQhAAAIQgAAEIAABCEAAAhBwIODfdOzf9qGv5VB4mIAABCAAAQhAAAIQgAAEIAABCEAAAhDoSyCg6dgX1orM6GhOUQbfFD4mQwACEIAABCAAAQhAAAIQgAAEIAABHwIRTUcaPz7aYEVNgNJTI2MCBCAAAQhAAAIQgAAEIAABCEAAAhAIIBDRdGz+Bevgxlaw+YAawiQEIAABCEAAAhCAAAQgAAEIQAACEIAABL4QCGk6whgCWwjQsN2CHacQgAAEIAABCEAAAhCAAAQgAAEIQOA7gZimI80fKm0DAcpuA3RcQgACEIAABCAAAQhAAAIQgAAEIACBCwIxTcfOX7Cms8VCggAEIAABCEAAAhCAAAQgAAEIQAACEIDAI4GgpmPnrmN0RdHVNBIGnBEc0yAAAQhAAAIQgAAEIAABCEAAAhCAgDeBqKajd5zYg8CAAD1HSgQCEIAABCAAAQhAAAIQgAAEIAABCGQhENZ0pAWUReJD4qDgDhGaNCEAAQhAAAIQgAAEIAABCEAAAhCoQCCs6dj1C9b0tiqUNTFCAAIQgAAEIAABCEAAAhCAAAQgAAEI7CQQ13TcmVVt3/Q1DfoBzQCNKRCAAAQgAAEIQAACEIAABCAAAQhAIIhAYNORNlCQZpj9SYBioyogAAEIQAACEIAABCAAAQhAAAIQgEAiAoFNx65fsE6kHqH8IUDPkVKAAAQgAAEIQAACEIAABCAAAQhAAAKZCEQ2Hek6ZlKaWCAAAQhAAAIQgAAEIAABCEAAAhCAAAQgsIhAaNNxUQ64OZ0ALzqeXgHkDwEIQAACEIAABCAAAQhAAAIQgEAyArFNR5pByeTuGQ5l1lNXsoIABCAAAQhAAAIQgAAEIAABCECgLoHYpiNfsK5bGXUip+dYRysihQAEIAABCEAAAhCAAAQgAAEIQOAQAsFNR7qOh9QRaUIAAhCAAAQgAAEIQAACEIAABCAAAQhA4C+B6KYjqCEQTIAXHYMBYx4CEIAABCAAAQhAAAIQgAAEIAABCKgJhDcdaQmpNWGChgAFpqHFWAhAAAIQgAAEIAABCEAAAhCAAAQgsIRAeNORL1gv0fFYJ/Qcj5WexCEAAQhAAAIQgAAEIAABCEAAAhBITCC+6UjXMbH8hAYBCEAAAhCAAAQgAAEIQAACEIAABCAAAX8CC5qOdB39ZcPiHwK86EgpQAACEIAABCAAAQhAAAIQgAAEIACBhARWNB0Tpk1IPQjQc+yhI1lAAAIQgAAEIAABCEAAAhCAAAQg0I3AkqYjraFuZZMkHworiRCEAQEIQAACEIAABCAAAQhAAAIQgAAEvhJY0nTkC9aUXQQBeo4RVLEJAQhAAAIQgAAEIAABCEAAAhCAAATmCaxpOtJ1nFcKCxCAAAQgAAEIQAACEIAABCAAAQhAAAIQKEJgUdORrmOReqgUJi86VlKLWCEAAQhAAAIQgAAEIAABCEAAAhA4isCqpuNRUEl2BQF6jiso4wMCEIAABCAAAQhAAAIQgAAEIAABCFgILGs60iISy/NbPPLkgRTUyeqTOwQgAAEIQAACEIAABCAAAQhAAALJCSxrOnb5gjUdwRwVTc8xhw5EAQEIQAACEIAABCAAAQhAAAIQgAAErgisazp26TpSRxCAAAQgAAEIQAACEIAABCAAAQhAAAIQgMAjgYVNR7qO1KIbAV50dEOJIQhAAAIQgAAEIAABCEAAAhCAAAQg4E9gZdORrqNIP77APcZEz3HMiBEQgAAEIAABCEAAAhCAAAQgAAEIQGAfgaVNx31pOnqmJ+gI02iKnqMRHNMgAAEIQAACEIAABCAAAQhAAAIQgMAaAmubjjSL1qja3Atl1Fxg0oMABCAAAQhAAAIQgAAEIAABCECgPIG1TUe+YD0uGN6kHDGi5zgixL9DAAIQgAAEIAABCEAAAhCAAAQgAIHNBBY3HTt0HekK7q1Zeo57+eMdAhCAAAQgAAEIQAACEIAABCAAAQiMCaxuOnboOo6pMiKOAD3HOLZYhgAEIAABCEAAAhCAAAQgAAEIQAACTgSWNx0bdB1DX3UMNe5UNJiBAAQgAAEIQAACEIAABCAAAQhAAAIQgMATgfVNxwZdR0pqHwFedNzHHs8QgAAEIAABCEAAAhCAAAQgAAEIQEBKYEPTka7jgzi86PhcufQcpSubcRCAAAQgAAEIQAACEIAABCAAAQhAYCOBHU3H8l1HOoO7Kpae4y7y+IUABCAAAQhAAAIQgAAEIAABCEAAAhoCW5qOmgDPGks781Fveo5nLQeyhQAEIAABCEAAAhCAAAQgAAEIQKAsgT1Nx+rNI3qDWwq+etlsgYZTCEAAAhCAAAQgAAEIQAACEIAABCCwgcCepiNfsL6Wmmbm

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

------=_NextPart_01C9119B.74EB4AB0Content-Location: file:///C:/E328C6E5/P1006_files/image002.jpgContent-Transfer-Encoding: base64Content-Type: image/jpeg

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

------=_NextPart_01C9119B.74EB4AB0Content-Location: file:///C:/E328C6E5/P1006_files/filelist.xmlContent-Transfer-Encoding: quoted-printableContent-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office"> <o:MainFile HRef=3D"../P1006.htm"/> <o:File HRef=3D"image001.png"/>

<o:File HRef=3D"image002.jpg"/> <o:File HRef=3D"header.htm"/> <o:File HRef=3D"filelist.xml"/></xml>------=_NextPart_01C9119B.74EB4AB0--

Business

1. Introduction.. 2